Neurosurgical procedures

NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases

Retrieved on: 
Monday, April 1, 2019

SAN DIEGO, April 1, 2019 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of CohereXLIF, the first-of-its-kind lateral Porous PEEK implant for XLIF and lateral single-position surgery.

Key Points: 
  • SAN DIEGO, April 1, 2019 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of CohereXLIF, the first-of-its-kind lateral Porous PEEK implant for XLIF and lateral single-position surgery.
  • The NuVasive Advanced Materials Science implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond.
  • Cohere XLIF is the first product launch for XLIF and lateral single-position surgery applications using Porous PEEK technology.
  • Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion.

Midwest Orthopaedics At Rush First In Chicago To Use New Robotic Technology In Spine Surgery

Retrieved on: 
Monday, March 18, 2019

CHICAGO, March 18, 2019 /PRNewswire/ --Midwest Orthopaedics at Rush (MOR) is the first in Chicago to use the Mazor X Robotic Guidance Platform for some of its spinal fusion surgery patients.

Key Points: 
  • CHICAGO, March 18, 2019 /PRNewswire/ --Midwest Orthopaedics at Rush (MOR) is the first in Chicago to use the Mazor X Robotic Guidance Platform for some of its spinal fusion surgery patients.
  • The imaging component of the system provides a customized 'blueprint' of a patient's spine along with detailed locations for spinal screws.
  • The robotic arm helps guide the surgeon as he or she places the screws into the proper locations more efficiently.
  • MOR doctors are team physicians for the Chicago Bulls, Chicago White Sox, Chicago Fire Soccer Club and Joffrey Ballet.

United States Dura Substitute Procedures Outlook to 2025: Craniotomy & Spinal Dura Substitutes Procedures - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 5, 2019

The "United States Dura Substitute Procedures Outlook to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Dura Substitute Procedures Outlook to 2025" report has been added to ResearchAndMarkets.com's offering.
  • United States Dura Substitute Procedures Outlook to 2025 provides key procedures data on the United States Dura Substitute Procedures.
  • The report provides procedure volumes within market segments - Craniotomy Dura Substitutes Procedures and Spinal Dura Substitutes Procedures.
  • United States Dura Substitute Procedures volumes by segments - Craniotomy Dura Substitutes Procedures and Spinal Dura Substitutes Procedures.

KICVentures Announces Three New Developments in Spine Surgery

Retrieved on: 
Tuesday, February 5, 2019

MALDEN, Mass., Feb. 5, 2019 /PRNewswire-PRWeb/ --KICVentures, a Boston-based private investment firm leading in healthcare technology, announced today three exciting new developments in spine surgery in the areas of Motion Preservation and Biologics.

Key Points: 
  • MALDEN, Mass., Feb. 5, 2019 /PRNewswire-PRWeb/ --KICVentures, a Boston-based private investment firm leading in healthcare technology, announced today three exciting new developments in spine surgery in the areas of Motion Preservation and Biologics.
  • Professor Dr. K. Daniel Riew, a global leader in cervical spine surgery and an investor in AxioMed, helped the company design the cervical multi-level protocol.
  • AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs.
  • NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in all orthopedic surgery.

Deep Brain Stimulation Offers Fresh Hope for Parkinson's Patients

Retrieved on: 
Tuesday, February 5, 2019

Thanks to its technology, this medical device-called neurostimulator, sparked a revolution for Parkinson's patients, helping them lead a normal life.

Key Points: 
  • Thanks to its technology, this medical device-called neurostimulator, sparked a revolution for Parkinson's patients, helping them lead a normal life.
  • Neurosurgeon Ali Zrh, M.D., explained the deep brain stimulation treatment in detail.
  • For patients who do not respond to drug treatment at the desired level, we achieve successful results with DBS.
  • Deep brain stimulation surgery involves the placement of two electrodes into specific regions of the brain while the patient is awake.

Deep Brain Stimulation Offers Fresh Hope for Parkinson's Patients

Retrieved on: 
Tuesday, February 5, 2019

Thanks to its technology, this medical device-called neurostimulator, sparked a revolution for Parkinson's patients, helping them lead a normal life.

Key Points: 
  • Thanks to its technology, this medical device-called neurostimulator, sparked a revolution for Parkinson's patients, helping them lead a normal life.
  • Neurosurgeon Ali Zrh, M.D., explained the deep brain stimulation treatment in detail.
  • For patients who do not respond to drug treatment at the desired level, we achieve successful results with DBS.
  • Deep brain stimulation surgery involves the placement of two electrodes into specific regions of the brain while the patient is awake.

Spine Surgery Robots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026

Retrieved on: 
Tuesday, January 15, 2019

It also provides market attractiveness analysis, in terms of geography, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global spine surgery robots market.

Key Points: 
  • It also provides market attractiveness analysis, in terms of geography, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global spine surgery robots market.
  • Global Spine Surgery Robots Market: Key Segments
    Based on application, the global spine surgery robots market has been segmented into spinal fusion, minimally invasive procedures, scoliosis, osteoporotic compression fractures, and others.In terms of method, the market has been classified into minimally invasive surgery, and open surgery.
  • The global spine surgery robots market has been analyzed based on increasing regulatory scrutiny, technology trends, expenditure on emerging technologies, and presence of key players in various regions.
  • The global spine surgery robots market has been segmented as follows:
    Global Spine Surgery Robots Market, by Application

INSIGHTEC Announces FDA Approval of Exablate Neuro for the Treatment of Tremor-Dominant Parkinson's Disease

Retrieved on: 
Tuesday, December 18, 2018

The Exablate Neuro is a focused ultrasound device for performing incisionless thalamotomy guided by MR imaging.

Key Points: 
  • The Exablate Neuro is a focused ultrasound device for performing incisionless thalamotomy guided by MR imaging.
  • This expansion adds medication-refractory tremor from PD to the current Exablate Neuro indication for incisionless, focused ultrasound thalamotomy for medication-refractory essential tremor.
  • The company's award-winning Exablate Neuro is used by neurosurgeons to perform the Neuravive treatment to deliver immediate and durable tremor relief for essential tremor and tremor-dominant Parkinson's disease patients.
  • "Exablate," and "Exablate Neuro," as well as the "INSIGHTEC" logo, whether standing alone or in connection with the word " INSIGHTEC", are protected trademarks of INSIGHTEC.

Eisai Announces FDA Approval Of FYCOMPA® in Pediatric Patients As Young As 4 Years Old For The Treatment Of Partial-Onset Seizures

Retrieved on: 
Friday, September 28, 2018

"We are excited about the potential of FYCOMPA as an important tool to reduce the incidence of seizures among pediatric patients living with epilepsy.

Key Points: 
  • "We are excited about the potential of FYCOMPA as an important tool to reduce the incidence of seizures among pediatric patients living with epilepsy.
  • This milestone underscores our commitment to providing treatment options for children with epilepsy for whom there is still a significant unmet need."
  • Adverse reactions in pediatric patients 4 to
  • Final results of these studies supporting the FDA approval in pediatric patients 4 years and older will be presented at an upcoming medical meeting.

Boston Scientific launches GUIDE™ XT System for Visualization of Deep Brain Stimulation in Europe

Retrieved on: 
Wednesday, September 26, 2018

EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE XT System for visualization of Deep Brain Stimulation (DBS) in Europe.

Key Points: 
  • EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE XT System for visualization of Deep Brain Stimulation (DBS) in Europe.
  • The GUIDE XT System is the first DBS visualization system built for directionality that utilizes patient specific anatomy and stimulation field modeling.
  • The GUIDE XT System automatically detects the location of the leads, implanted by a neurosurgeon, in the imaging of the brain.
  • "Unlike visualization systems that use a generic atlas, the GUIDE XT System enables us to visualize the lead placement in the patient's brain.